Welcome to DZIF
It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues.
When disciplines merge
DZIF Professor Mark Brönstrup is paving the way for new drugs against infectious diseases.
Researchers discover novel antibiotic agent
DZIF-Scientist Dr Tanja Schneider and her group at the University of Bonn participated in a hopeful discovery: Teixobactin is the name of a new antibiotic compound which is effective against a broad spectrum of pathogens. Photo: University of Bonn
EBOKON: Strengthening Ebola Research
The German Center for Infection Research (DZIF) has initiated a consortium to strengthen Ebola research and close the knowledge gaps as quickly as possible in the fight against the epidemic.
The European Congress of Clinical Microbiology and Infectious Diseases will take place 25 to 28 April 2015 in Copenhagen, Denmark. The DZIF will be present.
19 January 2015 - PRESS RELEASE
An international group of scientists unraveled for the first time the global spread of multidrug resistant (MDR) Mycobacterium tuberculosis (MTB) strains. The study shows that efficient tuberculosis (TB) surveillance based on molecular methods is essential to detect outbreaks of MDR-TB strains and to contain the global emergence of MDR-TB. DZIF scientists from the Reserch Center Borstel led the study in cooperation with French colleagues.
[ more ]
08 January 2015 - PRESS RELEASE
07 January 2015 - PRESS RELEASE
DZIF e.V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL email@example.com